OpenOnco · Diagnostic · Suspect HCC · HCV-cirrhosis + LI-RADS 5 + AFP 480
← Back to galleryFeedback on this case
OpenOnco · Workup Brief · DIAGNOSTIC PHASE
Pre-tumor-board workup brief
DPLAN-PZ-DIAG-HCC-001-V1 · v1 · 2026-05-13
Patient
PZ-DIAG-HCC-001 · suspicion lineage: hepatocellular_carcinoma
Tissues: liver · Hypotheses: DIS-HCC
59M HCV-cirrhosis (Child-Pugh A6, MELD 9) post-DAA sofosbuvir/velpatasvir 12 weeks → SVR12 confirmed 4 years ago. On surveillance US-q6mo + AFP. New 3.8 cm hepatic mass detected on routine US (right hepatic lobe segment 7), AFP rose 12 → 480 ng/mL over 6 months. Multi-phase contrast CT: arterial_phase_hyperenhancement + portal_venous_washout + capsular appearance → LI-RADS_5 (definitive HCC by imaging in cirrhotic patient per AASLD criteria). No portal vein invasion, no extrahepatic disease. Esophageal varices grade 1 on prior EGD (2 years ago — needs re-screening pre-systemic Tx). Eligible for systemic therapy or curative bridging (TACE/transplant) per BCLC.

Workup steps (8)

MDT brief

MDT talk tree (3 steps)

#OwnerTopicAction
1pathologistSpecialist review Any suspicion requires biopsy — pathologist plans site selection, IHC panel, ancillary tests.
2radiologistSpecialist review Stage / restaging imaging + biopsy guidance — radiologist.
3surgical_oncologistSpecialist review Suspected solid tumor — resectability assessment, biopsy approach.

Skills (required) — mandatory virtual specialists (2)

  • Pathologist (general) required
    Any suspicion requires biopsy — pathologist plans site selection, IHC panel, ancillary tests.
  • Radiologist required
    Stage / restaging imaging + biopsy guidance — radiologist.

Skills (recommended) — for consideration (1)

  • Surgical oncologist recommended
    Suspected solid tumor — resectability assessment, biopsy approach.
Technical MDT skill metadata (3/16 activated in this plan)
All registered virtual specialists. ✓ — activated for this case; ○ — not activated (available for other clinical scenarios).
Specialistskill_idVersionLast reviewedSign-offsDomain
Cellular therapy specialist (CAR-T)cellular_therapy_specialistv0.1.02026-04-250cellular_therapy
Clinical pharmacistclinical_pharmacistv0.1.02026-04-250clinical_pharmacy
Hematologist / oncohematologisthematologistv0.1.02026-04-250hematology_oncology
Hematopathologist (lymphoma / leukemia / myeloma)hematopathologistv0.1.02026-04-250hematopathology
Infectious disease / hepatologyinfectious_disease_hepatologyv0.1.02026-04-250infectious_diseases
Medical oncologist (solid-tumor chemotherapist)medical_oncologistv0.1.02026-04-250solid_oncology
Molecular geneticist / molecular oncologistmolecular_geneticistv0.1.02026-04-250molecular_oncology
Palliative carepalliative_carev0.1.02026-04-250palliative_care
Pathologist (general)pathologistv0.1.02026-04-250pathology
Primary care / family physicianprimary_carev0.1.02026-04-250primary_care
Psycho-oncologistpsychologistv0.1.02026-04-250psychosocial
Radiation oncologistradiation_oncologistv0.1.02026-04-250radiation_oncology
Radiologistradiologistv0.1.02026-04-250diagnostic_imaging
Social worker / case managersocial_worker_case_managerv0.1.02026-04-250psychosocial
Surgical oncologistsurgical_oncologistv0.1.02026-04-250surgical_oncology
Transplant specialist (BMT)transplant_specialistv0.1.02026-04-250cellular_therapy